Skip to main content
SpringerLink
Log in

Epidemiology

  • Chapter
  • First Online:
Diffuse Gastric Cancer

  • 351 Accesses

Abstract

Recent decades have witnessed a progressive reduction in the incidence and mortality of gastric cancer worldwide. This trend mainly relates to the reduction of intestinal-type gastric cancer and could be attributed to the knowledge and control of risk factors such as Helicobacter pylori and other dietary and environmental factors. The diffuse gastric cancer maintains a relatively stable incidence. Considering that hereditary diffuse gastric cancer (HDGC), determined by germline pathogenic mutations in the CDH1 gene, is responsible for a small portion of diffuse gastric cancer cases, the underlying cause that would explain the unchanged incidence of diffuse gastric cancer is largely unknown. Further investigations into the relationship between risk factors and diffuse gastric cancer tumorigenesis may lead to improvements in cancer prevention, screening, and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Global Burden of Disease Cancer Collaboration. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505–27.

    Article  PubMed Central  Google Scholar 

  2. Parkin DM. Epidemiology of cancer: global patterns and trends. Toxicol Lett. 1998;102–103:227–34.

    Article  PubMed  Google Scholar 

  3. Corso G, et al. History, pathogenesis, and management of familial gastric cancer: original study of John XXIII’s family. Biomed Res Int. 2013;2013, 385132

    Google Scholar 

  4. Nagini S. Carcinoma of the stomach: a review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol. 2012;4(7):156–69.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Bertuccio P, et al. Recent patterns in gastric cancer: a global overview. Int J Cancer. 2009;125(3):666.

    Article  CAS  PubMed  Google Scholar 

  6. Anderson WF, et al. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA. 2010;303(17):1723.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Pernot S, Voron T, Perkins G, et al. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. World J Gastroenterol. 2015;21(40):11428–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Laurén P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.

    Article  PubMed  Google Scholar 

  9. Lauwers GY, Carneiro F, Graham DY, et al. Gastric carcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC; 2010. p. 48–58.

    Google Scholar 

  10. The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–9.

    Article  CAS  Google Scholar 

  11. Chen YC, Fang WL, Wang RF, et al. Clinicopathological variation of Lauren classification in gastric cancer. Pathol Oncol Res. 2016;22(1):197–202.

    Article  PubMed  Google Scholar 

  12. Jaehn P, Holleczek B, Becher H, Winkler V. Histologic types of gastric cancer among migrants from the former Soviet Union and the general population in Germany: what kind of prevention do we need? Eur J Gastroenterol Hepatol. 2016;28(8):863–70.

    Article  PubMed  Google Scholar 

  13. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risk Hum. 1994;61:1–241.

    Google Scholar 

  14. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784–9.

    Article  CAS  PubMed  Google Scholar 

  15. Carneiro F, Charlton A, Huntsman DG. Hereditary diffuse gastric cancer. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC; 2010. p. 59–63.

    Google Scholar 

  16. Ford AC, Forman D, Hunt R, Yuan Y, Moayyedi P. Helicobacter pylori eradication for the prevention of gastric neoplasia. Cochrane Database Syst Rev. 2015;(7):CD005583.

  17. Take S, Mizuno M, Ishiki K, et al. The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori. J Gastroenterol. 2011;46(3):318–24.

    Article  PubMed  Google Scholar 

  18. Sasco AJ, Secretan MB, Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer. 2004;45(Suppl 2):S3–9.

    Article  PubMed  Google Scholar 

  19. González CA, Jakszyn P, Pera G, et al. Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2006;98:345.

    Article  PubMed  Google Scholar 

  20. Bouvard V, Loomis D, Guyton KZ, et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol. 2015;16(16):1599–600.

    Article  PubMed  Google Scholar 

  21. Fang X, Wei J, He X, et al. Landscape of dietary factors associated with risk of gastric cancer: a systematic review and dose-response meta-analysis of prospective cohort studies. Eur J Cancer. 2015;51(18):2820–32.

    Article  PubMed  Google Scholar 

  22. Hoang BV, Lee J, Choi IJ, et al. Effect of dietary vitamin C on gastric cancer risk in the Korean population. World J Gastroenterol. 2016;22(27):6257–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Zhang Z, Xu G, Ma M, Yang J, Liu X. Dietary fiber intake reduces risk for gastric cancer: a meta-analysis. Gastroenterology. 2013;145(1):113.

    Article  PubMed  Google Scholar 

  24. Park B, Shin A, Park SK, et al. Ecological study for refrigerator use, salt, vegetable, and fruit intakes, and gastric cancer. Cancer Causes Control. 2011;22:1497.

    Article  PubMed  Google Scholar 

  25. Yang P, Zhou Y, Chen B, et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Eur J Cancer. 2009;45(16):2867–73.

    Article  PubMed  Google Scholar 

  26. Takada K. Epstein-Barr virus and gastric carcinoma. Mol Pathol. 2000;53(5):255.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Kusano M, Toyota M, Suzuki H, et al. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus. Cancer. 2006;106(7):1467–79.

    Article  CAS  PubMed  Google Scholar 

  28. Lee JH, Kim SH, Han SH, et al. Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis. J Gastroenterol Hepatol. 2009;24(3):354–65.

    Article  PubMed  Google Scholar 

  29. Edgren G, Hialgrim H, Rostgaard K, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol. 2010;172(11):1280–5.

    Article  PubMed  Google Scholar 

  30. Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature. 1998;392:402–5.

    Article  CAS  PubMed  Google Scholar 

  31. Rashid H, Alam K, Afroze D, et al. Hypermethylation status of E-cadherin gene in gastric cancer patients in a high incidence area. Asian Pac J Cancer Prev. 2016;17(6):2757–60.

    PubMed  Google Scholar 

  32. van der Post RS, Vogelaar IP, Carneiro F, et al. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 2015;52(6):361–74.

    Article  CAS  PubMed  Google Scholar 

  33. Carneiro F, Huntsman DG, Smyrk TC, et al. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol. 2004;203:681–7.

    Article  CAS  PubMed  Google Scholar 

  34. McDonald AM, Sarfati D, Baker MG, et al. Trends in Helicobacter pylori infection among Māori, Pacific, and European birth cohorts in New Zealand. Helicobacter. 2015;20(2):139–45.

    Article  PubMed  Google Scholar 

  35. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process – first American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735–40.

    PubMed  CAS  Google Scholar 

  36. Haastrup P, Paulsen MS, Zwisler JE, et al. Rapidly increasing prescribing of proton pump inhibitors in primary care despite interventions: a nationwide observational study. Eur J Gen Pract. 2014;20(4):290–3.

    Article  PubMed  Google Scholar 

  37. Attwood SE, Ell C, Galmiche JP, et al. Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Aliment Pharmacol Ther. 2015;41(11):1162–74.

    Article  CAS  PubMed  Google Scholar 

  38. Ianiro G, Molina-Infante J, Gasbarrini A. Gastric microbiota. Helicobacter. 2015;20(Suppl 1):68–71.

    Article  PubMed  Google Scholar 

  39. Henson DE, Dittus C, Younes M, Nguyen H, Albores-Saavedra JA. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973–2000: increase in the signet ring cell type. Arch Pathol Lab Med. 2004;128:765–70.

    PubMed  Google Scholar 

  40. Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev. 2009;18(7):1945–52.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Núcleo de Pesquisas em Oncologia, Hospital Universitário João de Barros Barreto, Universidade Federal do Pará, Guamá, Belém, Pará, Brazil

    Williams Fernandes Barra, Samia Demachki, Geraldo Ishak & Paulo Pimentel de Assumpção

Authors
  1. Williams Fernandes Barra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Samia Demachki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Geraldo Ishak
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paulo Pimentel de Assumpção
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Instituto do Câncer do Estado de São Paulo, São Paulo, São Paulo, Brazil

    Tiago Biachi de Castria

  2. CLION, Salvador, Bahia, Brazil

    Rodrigo Santa Cruz Guindalini

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Barra, W.F., Demachki, S., Ishak, G., de Assumpção, P.P. (2018). Epidemiology. In: de Castria, T., Guindalini, R. (eds) Diffuse Gastric Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-95234-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-95234-5_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-95233-8

  • Online ISBN: 978-3-319-95234-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation